Home » MYLAN ANNOUNCES FINAL APPROVAL FOR BISOPROLOL FUMARATE TABLETS
MYLAN ANNOUNCES FINAL APPROVAL FOR BISOPROLOL FUMARATE TABLETS
December 20, 2005
Mylan Laboratories has received final FDA approval for its abbreviated new drug
application for bisoprolol fumarate in 5- and 10-mg tablets. The product is
the generic equivalent of Duramed Pharmaceuticals' beta-blocker Zebeta.